Answers are grounded in this paper and cite their sources.
Explores personalised revaccination improving protection in paediatric cancer survivors, indicating potential for enhanced immunity.
Immune recovery following paediatric cancer therapy is highly variable, particularly among hematologic malignancies. Personalised revaccination strategies incorporating comprehensive immunological workups may optimise protection against vaccine-preventable diseases.
No takes yet. Share an insight, caveat, or question.
Jurkowicz et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: